Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Variants in Sulfonylurea Dependence
NCT04123587Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2019
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Primary endpoint: List of previously found candidate variants at 20 weeks. Started Sep 2019; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04123587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123587.